Feedback / Questions
efimosfermin alfa (BOS-580) - Boston Pharma
https://www.businesswire.com/news/home/20250428674777/en/Boston-Pharmaceuticals-to-Present-the-Effect-of-Efimosfermin-Alfa-on-Collagen-Biomarkers-in-Patients-with-F2-and-F3-MASH-at-EASL-Congress-2025
Apr 28, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next